Iterum Therapeutics

$0.82
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.0015 (+0.18%) Today
-$0.0225 (-2.67%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell ITRM and other stocks, options, and ETFs commission-free!

About ITRM

Iterum Therapeutics plc Ordinary Share, also called Iterum Therapeutics, is a pharmaceutical company, which engages in the development and commercialization of sulopenem to be potentially the first and only oral and intravenous (IV) branded penem available. The company was founded by Corey N. Fishman on June 24, 2015 and is headquartered in Dublin, Ireland. The listed name for ITRM is Iterum Therapeutics plc Ordinary Share.

CEO
Corey N. Fishman
Employees
44
Headquarters
Dublin, Dublin
Founded
2015
Market Cap
36.26M
Price-Earnings Ratio
Dividend Yield
Average Volume
17.25M
High Today
$0.8773
Low Today
$0.78
Open Price
$0.80
Volume
8.21M
52 Week High
$7.19
52 Week Low
$0.451

Collections

ITRM Earnings

-$2.15
-$1.43
-$0.72
$0.00
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Mar 11, Pre-Market

You May Also Like